Ivax Diagnostics, Inc. News - IVD

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or...

IVAX Diagnostics, Inc. Announces Name Change to ERBA Diagnostics, Inc.

ZIVAX Diagnostics, Inc. (NYSE MKT: IVD), a fully integrated in vitro diagnostics company, announced today that its corporate name...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 _________________________________ FORM 8-K...

- Proxy Statement (definitive) (DEF 14A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 SCHEDULE 14A Proxy...

- Amended Quarterly Report (10-Q/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q /A Amendment No. 1 QUARTERLY...

- Quarterly Report (10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 _________________________________ ...

IVAX Diagnostics, Inc. Reports First Quarter 2012 Financial Results

IVAX Diagnostics, Inc. (NYSE Amex: IVD), a fully integrated in vitro diagnostics company, reports its financial results for the...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or...

- Notification that Quarterly Report will be submitted late (NT 10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 1-14798 ...

- Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 SCHEDULE 14A Proxy...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

IVAX Diagnostics, Inc. Reports Fourth Quarter and Full Year 2011 Financial Results

IVAX Diagnostics, Inc. (NYSE Amex: IVD), a fully integrated in vitro diagnostics company, reports its financial results for the...

- Annual Report (10-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION...

- Notification that Annual Report will be submitted late (NT 10-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 1-14798 ...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Ivax Diagnostics, Inc. (IVD)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

IVD News

- Current report filing (8-K)

IVAX Diagnostics, Inc. Announces Name Change to ERBA Diagnostics, Inc.

- Current report filing (8-K)

- Proxy Statement (definitive) (DEF 14A)

- Amended Quarterly Report (10-Q/A)

- Quarterly Report (10-Q)

- Current report filing (8-K)

IVAX Diagnostics, Inc. Reports First Quarter 2012 Financial Results

- Current report filing (8-K)

- Notification that Quarterly Report will be submitted late (NT 10-Q)

- Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)

- Statement of Changes in Beneficial Ownership (4)

IVAX Diagnostics, Inc. Reports Fourth Quarter and Full Year 2011 Financial Results

- Annual Report (10-K)

- Notification that Annual Report will be submitted late (NT 10-K)

IVD Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Ivax Diagnostics, Inc. (IVD) News

Ivax Diagnostics, Inc. (IVD)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

IVD News

- Current report filing (8-K)

IVAX Diagnostics, Inc. Announces Name Change to ERBA Diagnostics, Inc.

- Current report filing (8-K)

- Proxy Statement (definitive) (DEF 14A)

- Amended Quarterly Report (10-Q/A)

- Quarterly Report (10-Q)

- Current report filing (8-K)

IVAX Diagnostics, Inc. Reports First Quarter 2012 Financial Results

- Current report filing (8-K)

- Notification that Quarterly Report will be submitted late (NT 10-Q)

- Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)

- Statement of Changes in Beneficial Ownership (4)

IVAX Diagnostics, Inc. Reports Fourth Quarter and Full Year 2011 Financial Results

- Annual Report (10-K)

- Notification that Annual Report will be submitted late (NT 10-K)

IVD Discussion

Your Recent History